The global glutamine market is estimated to be valued at USD 135.13 million in 2024 and is projected to reach USD 185.16 million by 2034, growing at a compound annual growth rate (CAGR) of 3.2% over the forecast period.
The glutamine market is experiencing notable growth, driven by its diverse applications and increasing awareness of its health benefits. As an essential amino acid, glutamine plays a vital role in protein synthesis, immune function, and maintaining digestive health, particularly the integrity of the intestinal lining. This has made glutamine a popular dietary supplement, with widespread recognition among healthcare professionals and consumers for its ability to promote overall well-being.
Glutamine’s role in healthcare continues to expand, particularly in managing chronic conditions. For example:
Recent advancements underline the growing potential of glutamine:
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/glutamine-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5119
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The medical imaging market is witnessing rapid expansion worldwide, and Europe is emerging as a key contributor to this global… Read More
The global continuous glucose monitoring devices market size is calculated at USD 4.97 in 2024. Living with diabetes in Canada… Read More
The surgical sutures market in the United States is showing steady and promising growth, and here’s why! 👇 👵👴 An… Read More
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data… Read More